Get started
Author

Luigi Giuseppe Atripaldi

Observed names: Atripaldi L, Atripaldi, Luigi, L Atripaldi, L. Atripaldi, Luigi Atripaldi
Observed institutions: University of Crete, University of Campania "Luigi Vanvitelli", Istituto Superiore di Sanità, Ospedale Antonio Cardarelli, Federico II University Hospital, Ospedale Monaldi, Ospedale D. Cotugno, University of Naples Federico II
ORCID: 0000-0002-8380-5175
Observed ORCID: 0000-0002-8380-5175
OpenAlex ID: A5018916329
COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study
2020 · F.M. Fusco, M. Pisaturo, et al. · Journal of Hospital Infection · 106
PDF
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
2020 · Vincenzo Montesarchio, Roberto Parrella, et al. · Journal for ImmunoTherapy of Cancer · 84
PDF
Cytokine signature and COVID-19 prediction models in the two waves of pandemics
2021 · Serena Cabaro, Vittoria D’Esposito, et al. · Scientific Reports · 71
PDF
Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing
2021 · Christine C. Ginocchio, Carolina Garcia-Mondragon, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 68
PDF
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion
2022 · Nicola Coppola, Alberto Enrico Maraolo, et al. · Antibiotics · 44
PDF
Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
2016 · Massimiliano Berretta, Michele Caraglia, et al. · Frontiers in Pharmacology · 44
PDF
Long-chain polyphosphates impair SARS-CoV-2 infection and replication
2021 · Veronica Ferrucci, Dae-Young Kong, et al. · Science Signaling · 42
Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting
2020 · E. Durante-Mangoni, R. Andini, et al. · Clinical Microbiology and Infection · 32
PDF
Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution
2006 · A Perrella, L Vitiello, et al. · Gut · 29
PDF
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis
2021 · Simone Meini, Emanuela Sozio, et al. · Frontiers in Medicine · 28
PDF
Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients
2021 · Francesco Perna, Sara Bruzzaniti, et al. · Clinical Immunology · 27
Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
2022 · Antonio Grimaldi, Francesco Panariello, et al. · Genome Medicine · 26
PDF
Impaired function of CD4+/CD25+ T regulatory lymphocytes characterizes the self‐limited hepatitis A virus infection
2007 · Alessandro Perrella, Laura Vitiello, et al. · Journal of Gastroenterology and Hepatology · 19
No Detection of SARS-CoV-2 in Animals Exposed to Infected Keepers: Results of a COVID-19 Surveillance Program
2021 · Pellegrino Cerino, Carlo Buonerba, et al. · Future Science OA · 17
Acute Rejection After Liver Transplantation: Is There a Specific Immunological Pattern?
2006 · O. Perrella, C. Sbreglia, et al. · Transplantation Proceedings · 17
Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study
2017 · Antonio D’Onofrio, Vincenzo Russo, et al. · EP Europace · 16
Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin
2009 · A. Perrella, C. Sbreglia, et al. · Scandinavian Journal of Gastroenterology · 15
Seroprevalence of SARS-CoV-2-specific Antibodies in the Town of Ariano Irpino (Avellino, Campania, Italy): a population-based Study
2021 · Pellegrino Cerino, Annachiara Coppola, et al. · Future Science OA · 14
Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
2021 · Rosa Zampino, Domenico Iossa, et al. · BMC Infectious Diseases · 13
PDF
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
2017 · Raffaele Di Francia, Luigi Atripaldi, et al. · Frontiers in Pharmacology · 13
PDF
Elevated CD4+/CD25+ T-cell Frequency and Function During Hepatitis C Virus Recurrence After Liver Transplantation
2009 · A. Perrella, G. Arenga, et al. · Transplantation Proceedings · 13
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
2020 · Maria Carmela Piccirillo, Paolo Ascierto, et al. · Contemporary Clinical Trials · 12
Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis
2006 · Oreste Perrella, Costanza Sbreglia, et al. · Neurological Research · 12
Persons living with HIV may be reluctant to access to COVID-19 testing services: data from ‘D. Cotugno’ Hospital, Naples, Southern Italy
2020 · Francesco Maria Fusco, Vincenzo Sangiovanni, et al. · AIDS · 9
Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose
2020 · Vincenzo Russo, Anna Rago, et al. · Monaldi Archives for Chest Disease · 9
PDF
Works count: 94
Citation count: 912
H-index: 16
I10-index: 23
Year
Topic
Type